Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug...
Canon Medical has announced the launch of Altivity, a new AI innovation brand, that consolidates machine learning and deep learning technologies to deliver uncompromised...
Neurolign Technologies™, the global leader in clinical eye-tracking and neuro-functional diagnostic testing, announced the expansion of an ongoing strategic partnership with the Henry M....
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) today announced their agreement with Molecular Targeting Technologies, Inc. (MTTI), a clinical stage biotech company focused on developing innovative...
